Stephen D. COLLINS,Peter GOLDSTEIN,Joshua T. JOHNSTONE
申请号：
US15985390
公开号：
US20180333365A1
申请日:
2018.05.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present application discloses pharmaceutical compositions for modified release of huperzine. The pharmaceutical compositions and methods described herein, allow for dosing of huperzine at higher therapeutic thresholds, while avoiding rapid serum peak plasma levels, thereby avoiding the adverse nausea and vomiting associated with the immediate release pharmaceutical compositions. Methods of treating neurological disorders and/or seizure disorders with the modified release compositions is also described.
